Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Urinary Incontinence
NCT02983461Phase 1Active, not recruiting
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Mar 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP-001 in urinary incontinence (UI) (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Urinary Incontinence as measured by Pad Test at 10 weeks. Started Mar 2017; status: active, not recruiting.
02
Drugs
ASP-001
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT02983461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983461.